All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
XS-0822-YF2141 | Anti-Mouse DCLK2 (XW-301) m(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Mouse | XW-301 | Rat | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2142 | Anti-Human DCLK2 (XW-302) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-302 | Mouse | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2143 | Anti-Human DCLK2 (XW-303) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-303 | Human | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-1122-YF3981 | Anti-DCLK2 TCR-ABR (scFv-CD3δ, XW-301) CAR Plasmid, pCDCAR1 | Mouse | XW-301 | Rat | scFv-CD3δ | Lentiviral vector | T Cell | ||
XS-1122-YF3982 | Anti-DCLK2 TCR-ABR (scFv-CD3δ, XW-302) CAR Plasmid, pCDCAR1 | Human | XW-302 | Mouse | scFv-CD3δ | Lentiviral vector | T Cell | ||
XS-1122-YF3983 | Anti-DCLK2 TCR-ABR (scFv-CD3δ, XW-303) CAR Plasmid, pCDCAR1 | Human | XW-303 | Human | scFv-CD3δ | Lentiviral vector | T Cell | ||
XS-1122-YF4901 | Anti-DCLK2 TCR-ABR (scFv-CD3ε, XW-301) CAR Plasmid, pCDCAR1 | Mouse | XW-301 | Rat | scFv-CD3ε | Lentiviral vector | T Cell | ||
XS-1122-YF4902 | Anti-DCLK2 TCR-ABR (scFv-CD3ε, XW-302) CAR Plasmid, pCDCAR1 | Human | XW-302 | Mouse | scFv-CD3ε | Lentiviral vector | T Cell | ||
XS-1122-YF4903 | Anti-DCLK2 TCR-ABR (scFv-CD3ε, XW-303) CAR Plasmid, pCDCAR1 | Human | XW-303 | Human | scFv-CD3ε | Lentiviral vector | T Cell | ||
XS-1122-YF5821 | Anti-DCLK2 (XW-301) h(CD28-CD3ζ) CAR, pAAV | Mouse | XW-301 | Rat | scFv-CD28-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
XS-1122-YF5822 | Anti-DCLK2 (XW-302) h(CD28-CD3ζ) CAR, pAAV | Human | XW-302 | Mouse | scFv-CD28-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
XS-1122-YF5823 | Anti-DCLK2 (XW-303) h(CD28-CD3ζ) CAR, pAAV | Human | XW-303 | Human | scFv-CD28-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
XS-1122-YF6741 | Anti-DCLK2 (XW-301) h(41BB-CD3ζ) CAR, pAAV | Mouse | XW-301 | Rat | scFv-41BB-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
XS-1122-YF6742 | Anti-DCLK2 (XW-302) h(41BB-CD3ζ) CAR, pAAV | Human | XW-302 | Mouse | scFv-41BB-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
XS-1122-YF6743 | Anti-DCLK2 (XW-303) h(41BB-CD3ζ) CAR, pAAV | Human | XW-303 | Human | scFv-41BB-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
XS-1122-YF7661 | Anti-DCLK2 (XW-301) h(CD28-41BB-CD3ζ) CAR, pAAV | Mouse | XW-301 | Rat | scFv-CD28-41BB-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
XS-1122-YF7662 | Anti-DCLK2 (XW-302) h(CD28-41BB-CD3ζ) CAR, pAAV | Human | XW-302 | Mouse | scFv-CD28-41BB-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
XS-1122-YF7663 | Anti-DCLK2 (XW-303) h(CD28-41BB-CD3ζ) CAR, pAAV | Human | XW-303 | Human | scFv-CD28-41BB-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
XS-0123-ZP596 | Anti-DCLK2 (CB-P82) h(scFv-CD3ε) TRuC, pCDTRC1 | Mouse | CB-P82 | Rat | scFv-CD3ε | Lentiviral vector | T cell | ||
XS-0323-ZP596 | Anti-DCLK2 (CB-P82 scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Mouse | CB-P82 | Rat | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION